FMBTD
ITCI
First Midwest Bank Trust Division’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $3.99M | Sell |
76,281
-20,077
| -21% | -$1.05M | 0.51% | 41 |
|
|
2021
Q3 | $3.59M | Buy |
96,358
+15,327
| +19% | +$571K | 0.51% | 46 |
|
|
2021
Q2 | $3.31M | Sell |
81,031
-11,473
| -12% | -$468K | 0.45% | 57 |
|
|
2021
Q1 | $3.14M | Sell |
92,504
-42,387
| -31% | -$1.44M | 0.43% | 57 |
|
|
2020
Q4 | $4.29M | Sell |
134,891
-95,312
| -41% | -$3.03M | 0.62% | 40 |
|
|
2020
Q3 | $5.91M | Sell |
230,203
-40,016
| -15% | -$1.03M | 0.92% | 19 |
|
|
2020
Q2 | $6.94M | Buy |
270,219
+95,625
| +55% | +$2.45M | 1.13% | 10 |
|
|
2020
Q1 | $2.68M | Buy |
174,594
+72,705
| +71% | +$1.12M | 0.49% | 45 |
|
|
2019
Q4 | $3.5M | Buy |
+101,889
| New | +$3.5M | 0.47% | 47 |
|
|
2019
Q3 | – | Sell |
-600,236
| Closed | -$7.79M | – | 377 |
|
|
2019
Q2 | $7.79M | Buy |
600,236
+246,644
| +70% | +$3.2M | 1.11% | 11 |
|
|
2019
Q1 | $4.31M | Buy |
353,592
+26,366
| +8% | +$321K | 0.59% | 42 |
|
|
2018
Q4 | $3.73M | Buy |
327,226
+122,756
| +60% | +$1.4M | 0.56% | 42 |
|
|
2018
Q3 | $4.44M | Buy |
204,470
+25,880
| +14% | +$562K | 0.6% | 37 |
|
|
2018
Q2 | $3.16M | Buy |
178,590
+72,408
| +68% | +$1.28M | 0.45% | 52 |
|
|
2018
Q1 | $2.24M | Sell |
106,182
-80,938
| -43% | -$1.7M | 0.31% | 97 |
|
|
2017
Q4 | $2.71M | Buy |
187,120
+2,284
| +1% | +$33.1K | 0.34% | 76 |
|
|
2017
Q3 | $2.92M | Buy |
184,836
+28,487
| +18% | +$450K | 0.36% | 77 |
|
|
2017
Q2 | $1.94M | Buy |
156,349
+54,023
| +53% | +$671K | 0.24% | 112 |
|
|
2017
Q1 | $1.66M | Buy |
+102,326
| New | +$1.66M | 0.2% | 144 |
|